Gilead Sciences »

Allogene Therapeutics shares owned by Gilead Sciences

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Gilead Sciences from 13F filings

Historical chart of Gilead Sciences investment in Allogene Therapeutics

23:59:59.999Dec 30, 202423:59:59.999500:00:00Dec 31, 202400:00:00.000500:00:00.0012.463746M2.4637465M2.463747M2.4637475M2.463748M1.156688M1.1566885M1.156689M1.1566895M1.15669M
Value ($)Share countHistorical ALLO position of Gilead Sciences Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by Gilead Sciences consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by Gilead Sciences

Quarter filed Position value Share count Share price at filing
2024-12-31 $2.5M 1.2M 2.13

More positions owned by Gilead Sciences

Arcellx Common Stock (ACLX)
Galapagos Nv Spon Adr (GLPG)
Arcus Biosciences Incorporated (RCUS)
Assembly Biosciences Com New (ASMB)
Merus N V (MRUS)
Kyverna Therapeutics (KYTX)
Leap Therapeutics Com New (LPTX)
Tango Therapeutics (TNGX)
Xilio Therapeutics (XLO)
Allovir (ALVR)
Hookipa Pharma Com New (HOOK)
Ikena Oncology (IKNA)
Allogene Therapeutics (ALLO)
Barinthus Biotherapeutics Pl Ads (BRNS)
Agenus Com New (AGEN)

View all positions for Gilead Sciences

Top funds holding Allogene Therapeutics

FMR
Tpg Gp A
BlackRock
Lynx1 Capital Management
Vanguard Group
State Street Corporation
Capital World Investors
Citadel Advisors
PRIMECAP Management Company
T. Rowe Price Associates
Woodline Partners
Jpmorgan Chase & Co
Dimensional Fund Advisors
Geode Capital Management
Wildcat Capital Management

View all funds holding Allogene Therapeutics